Hongge Liang

5PUBLICATIONS
4CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 19, 2024
Hippo pathway in non-small cell lung cancer: mechanisms, potential targets, and biomarkers.

Hongge Liang, Yan Xu, Jing Zhao

|Jan 29, 2021
Prognostic impact of maximum standardized uptake value on 18 F-FDG PET/CT imaging of the primary lung lesion on survival in advanced non-small cell lung cancer: A retrospective study.

Xiaoling Qiu, Hongge Liang, Wei Zhong

|Apr 11, 2020
MET Oncogene in Non-Small Cell Lung Cancer: Mechanism of MET Dysregulation and Agents Targeting the HGF/c-Met Axis.

Hongge Liang, Mengzhao Wang

|Mar 05, 2020
Patterns of response in metastatic NSCLC during PD-1 or PD-L1 inhibitor therapy: Comparison of the RECIST 1.1 and iRECIST criteria.

Hongge Liang, Yan Xu, Minjiang Chen

|Oct 01, 2019
Elevated levels of pre-treatment lactate dehydrogenase are an unfavorable predictor factor in patients with EML4-ALK rearrangement non-small cell lung cancer treated with crizotinib.

Hongge Liang, Di Ma, Yan Xu

Pageof 1

Frequent Collaborators

3 joint publications

Yan Xu

2 joint publications

Minjiang Chen

1 joint publications

Jing Zhao

1 joint publications

Mengzhao Wang